Cargando…
Altered states, alkaloids, and catatonia: Monoaminoxidase inhibitors and their role in the history of psychopharmacology
Monoamine oxidases are mitochondrial enzymes that catalyze the oxidative deamination of biogenic amines (adrenaline, noradrenaline, serotonin, and dopamine), causing their inactivation and subsequently playing a fundamental role in the homeostasis of various neurotransmitters. As the regulation of t...
Autores principales: | Buda, Octavian, Hostiuc, Sorin, Popa-Velea, Ovidiu, Boroghina, Steluta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764005/ https://www.ncbi.nlm.nih.gov/pubmed/36561338 http://dx.doi.org/10.3389/fphar.2022.1053534 |
Ejemplares similares
-
Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature
por: Ciobanu, Adela Magdalena, et al.
Publicado: (2021) -
Alternative psychopharmacologic treatments for pediatric catatonia: a retrospective analysis
por: Smith, Joshua R., et al.
Publicado: (2023) -
Monoaminoxidase inhibitors as a cause of serotonin syndrome – a systematic case review based on meta-analytic principles
por: Truedson, P., et al.
Publicado: (2021) -
Psychopharmacology of anxiety disorders
por: Cassano, Giovanni B., et al.
Publicado: (2002) -
Evidence-based consensus guidelines for the management of catatonia:
Recommendations from the British Association for Psychopharmacology
por: Rogers, Jonathan P, et al.
Publicado: (2023)